Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Annual Meeting will reconvene at 9:00 a.m. Eastern time on May 18, 2022 and will continue to be held virtually at www.virtualshareholdermeeting.com/BXRX2022.
$10M and now another $2M??
See if they actually finish something!
The sky isn't falling. Just the low float that makes this very volatile. Still, a new low is a new low. Have a plan.
I'll be building for the bounce here soon.
Market up on FED bs yesterday like almost 1000 points, of course it gives it all back and then some very soon.
Follow the bouncing ball.
Still accumulating a bit here. The up gap to $4 is very tempting indeed.
Time will tell.
Last buy right here mid 1.70's.
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surgery
Baudax Bio, Inc.
Tue, March 8, 2022, 5:00 AM·5 min read
In this article:
BXRX
-8.14%
Baudax Bio, Inc.
Baudax Bio, Inc.
MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced initiation of a clinical study evaluating the safety and pharmacokinetics (PK) of ANJESO (meloxicam) injection in pediatric patients (ages 2 to <17 years old) following surgery.
https://finance.yahoo.com/news/baudax-bio-initiates-phase-iv-130000680.html
Offering announced. I didn't see a price punched into the dead dog.
Great timing.
E-mail didn't hit me till after hours. Interesting. Took a nibble 3.25. Next will likely be closer to 2.50. Anexample would be when SYN did their RS, they're now under .30.
It'll take revs and strong news to dig out of this rut.
JMHO.
Trade wisely, lock in the green when you can. Again - JMHO.
VOLATILITY LENDS ITSELF TO OPPORTUNITY!!!
Splits. They're so predictable imo. Probably see under $3 show some life for a bit and then as the dilution continues it'll be back to the $ again.
Anything's possible though.
R/S 35 = 1 Still watch
BXRX
$0.256 $0.06 (30.35%) Vol 6.4M Heavy Day
Bid 0.256 Ask 0.26
Vol6.4M Heavy Day
Yes, they've stated that as one of the items to vote Feb 9th. The timeline goes into the summer to execute though there is certainly still the possibility the split won't be needed... IF "if" happens.
R/S on table .. watch
BXRX
Correction: the sabby reference is not for BXRX. Mixed my DD with another bio. But the pinch is still very relevant. Until it isn't.
I have two things on my mind here. 1st is the amended form 13. Sabby has been one to watch for, how do I put it, well... sometimes when Sabby takes a position after a period of time there's quite the push. Noting that the company announced in their form 14 a reverse split (meeting in February) may take the thunder out of a major move, there could still be one that negates the need for the split. Fine with me.
Second, the chart is poised for a very powerful potential pinch. It's just after the New Year so tax selloff is now complete. A pinch with some solid news to keep the momentum going (an excellent article even) would be the fire that makes it happen.
https://ih.advfn.com/stock-market/NASDAQ/hepion-pharmaceuticals-HEPA/stock-news/86933501/amended-statement-of-ownership-sc-13g-a
BXRX daily
All my opinion of course.
Up pressure building nicely. Inverted head and shoulders forming.
BXRX daily
Make the move back over the $ before Christmas would ya!!!?
They'll get there. I'm still accumulating thinking each quarter will improve as they go.
I have to say, I like the looks of the daily here.
BXRX daily
LII's like the .58 for support. I'll take a few as well.
Still no news.
CEO buys, I buy. My last buy was .58's right there with them. I'll take more.
May see more form 4's soon.
https://ih.advfn.com/stock-market/NASDAQ/baudax-bio-BXRX/stock-news/86126181/statement-of-changes-in-beneficial-ownership-4
What are the rumors for all the volume?
BXRX
$BXRX 100k insider buy from Director
— TexMex (@TraderTexMex) August 31, 2021
Thanks for the alert Night Stalker! I didn't think to check for the form 4 filings...
http://www.openinsider.com/search?q=bxrx
If I had I may have added more. I loaded .58's just last week! I'm thinking in about a month or less this may be back over the $. BUT, that's just a WAG.
GLTA!
Early volume!
Buying. Form 4. Missed this from a couple days ago.
https://ih.advfn.com/stock-market/NASDAQ/baudax-bio-BXRX/stock-news/85313279/statement-of-changes-in-beneficial-ownership-4
Still liking the chart.
BXRX
I'm thinking things could get interesting around here.
kind of a shitty low quality call yesterday - how hard is it to do a conference call?
Had to know an offering was coming. They bump up these puppies just for that reason.
https://finance.yahoo.com/news/baudax-bio-announces-17-6-202400338.html
you've got the right name for today's action
[/Baudax Bio is a pharmaceutical company focused on therapeutics for acute care settings. The launch of the Company's first commercial product, ANJESO, began in June of 2020. Baudax's New Drug Application for ANJESO was approved by FDA on February 20, 2020 for the management the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. ANJESO is a once daily IV NSAID with preferential Cox-2 activity, which has successfully completed three Phase III clinical trials, including two pivotal efficacy trials, a large double-blind Phase III safety trial and other studies for the management of moderate to severe pain. As a non-opioid, IV meloxicam has the potential to overcome many of the issues associated with commonly prescribed opioid therapeutics, including respiratory depression, constipation, excessive nausea and vomiting, as well as having no addictive potential while maintaining meaningful analgesic effects for relief of pain. For more information please visit www.baudaxbio.com.
$BXRX
Followers
|
19
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
404
|
Created
|
11/26/19
|
Type
|
Free
|
Moderators |
March 26, 2020 | 17.57M |
CHURCHILL WINSTON J | Director | Mar 26 | Buy | 2.28 | 6,500 | 14,820 | 6,500 | Mar 30 08:00 PM |
CHURCHILL WINSTON J | Director | Mar 26 | Buy | 2.44 | 25,000 | 61,000 | 52,782 | Mar 30 08:00 PM |
Weisman Wayne | Director | Mar 26 | Buy | 2.29 | 10,000 | 22,900 | 40,582 | Mar 27 03:53 PM |
ALTOMARI ALFRED | Director | Mar 26 | Buy | 2.34 | 5,000 | 11,700 | 33,382 | Mar 27 03:51 PM |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |